Martin Petric

12.9k total citations · 2 hit papers
123 papers, 7.1k citations indexed

About

Martin Petric is a scholar working on Epidemiology, Infectious Diseases and Animal Science and Zoology. According to data from OpenAlex, Martin Petric has authored 123 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Epidemiology, 64 papers in Infectious Diseases and 20 papers in Animal Science and Zoology. Recurrent topics in Martin Petric's work include Viral gastroenteritis research and epidemiology (38 papers), Influenza Virus Research Studies (32 papers) and Respiratory viral infections research (28 papers). Martin Petric is often cited by papers focused on Viral gastroenteritis research and epidemiology (38 papers), Influenza Virus Research Studies (32 papers) and Respiratory viral infections research (28 papers). Martin Petric collaborates with scholars based in Canada, United States and United Kingdom. Martin Petric's co-authors include Mohamed A. Karmali, Raymond Tellier, Corazon Lim, Mel Krajden, Danuta M. Skowronski, Gaston De Serres, Suzana Sabaiduc, Robert C. Brunham, Grant Johnson and Nathalie Bastien and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Martin Petric

123 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of Severe Acute Respiratory Syndrome in Canada

2003 867 citations Bonnie Henry, Raymond Tellier et al. profile →
SPORADIC CASES OF HAEMOLYTIC-URAEMIC SYNDROME ASSOCIATED WITH FAECAL CYTOTOXIN AND CYTOTOXIN-PRODUCING ESCHERICHIA COLI IN STOOLS

1983 761 citations Martin Petric et al. profile →

Peers

Countries citing papers authored by Martin Petric

Since Specialization

Citations

This map shows the geographic impact of Martin Petric's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Petric with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Petric more than expected).

Fields of papers citing papers by Martin Petric

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Petric. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Petric. The network helps show where Martin Petric may publish in the future.

Co-authorship network of co-authors of Martin Petric

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Petric. A scholar is included among the top collaborators of Martin Petric based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Petric. Martin Petric is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada 2022 ·Canadian Medical Association Journal ·Danuta M. Skowronski, (unknown), Michael A. Irvine, Shinhye Kim, (unknown), Suzana Sabaiduc, (unknown), Romina C. Reyes, Bonnie Henry, Paul N. Levett, Martin Petric, Mel Krajden, Inna Sekirov	38
2	Mechanism-Based Covalent Neuraminidase Inhibitors with Broad-Spectrum Influenza Antiviral Activity 2013 ·Science ·Jin‐Hyo Kim, (unknown), Tom Wennekes, Hongming Chen, (unknown), Sabrina Buchini, Andrew G. Watts, Pat Pilling, Victor A. Streltsov, Martin Petric, Richard Liggins, Susan Barrett, Jennifer L. McKimm‐Breschkin, Masahiro Niikura, Stephen G. Withers	155
3	Use of Lean Response to Improve Pandemic Influenza Surge in Public Health Laboratories 2012 ·Emerging infectious diseases ·Judith L. Isaac‐Renton, (unknown), Natalie Prystajecky, Martin Petric, Annie Mak, (unknown), (unknown), (unknown), (unknown), (unknown), Jeff Stott, Joseph D. Miller	12
4	Estimates of Influenza Vaccine Effectiveness for 2007–2008 From Canada's Sentinel Surveillance System: Cross-Protection Against Major and Minor Variants 2012 ·The Journal of Infectious Diseases ·Naveed Z. Janjua, Danuta M. Skowronski, Gaston De Serres, (unknown), Natasha S. Crowcroft, Marsha Taylor, Anne‐Luise Winter, Travis Salway, Kevin Fonseca, Hugues Charest, Steven J. Drews, Suzana Sabaiduc, Nathalie Bastien, Yan Li, Jennifer L. Gardy, Martin Petric	48
5	A Sentinel Platform to Evaluate Influenza Vaccine Effectiveness and New Variant Circulation, Canada 2010–2011 Season 2012 ·Clinical Infectious Diseases ·Danuta M. Skowronski, Naveed Z. Janjua, Gaston De Serres, Anne‐Luise Winter, James A. Dickinson, Jennifer L. Gardy, Jonathan B. Gubbay, Kevin Fonseca, Hugues Charest, Natasha S. Crowcroft, Monique Douville Fradet, Nathalie Bastien, Yan Li, Mel Krajden, Suzana Sabaiduc, Martin Petric	86
6	Influenza B/Victoria Antigen Induces Strong Recall of B/Yamagata But Lower B/Victoria Response in Children Primed With Two Doses of B/Yamagata 2011 ·The Pediatric Infectious Disease Journal ·Danuta M. Skowronski, Travis Salway, Gaston De Serres, Brian J. Ward, Naveed Z. Janjua, Suzana Sabaiduc, Tracy Chan, Martin Petric	46
7	The de-guanidinylated derivative of peramivir remains a potent inhibitor of influenza neuraminidase 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Tracy Chan, (unknown), Martin Petric, Martin J. Boulanger, Jeremy E. Wulff	15
8	Seasonal Influenza Vaccine and Increased Risk of Pandemic A/H1N1‐Related Illness: First Detection of the Association in British Columbia, Canada 2010 ·Clinical Infectious Diseases ·Naveed Z. Janjua, Danuta M. Skowronski, Travis Salway, (unknown), E. D. Adams, Martin Petric, Suzana Sabaiduc, Tracy Chan, Annie Mak, Marcus Lem, Patrick Tang, David M. Patrick, Gaston De Serres, David Bowering	63
9	West Nile Virus Finally Debuts in British Columbia 10 Years After Its Introduction to North America 2010 ·Vector-Borne and Zoonotic Diseases ·Muhammad Morshed, Patrick Tang, Martin Petric, Mel Krajden, David Roth, Bonnie Henry, (unknown)	2
10	A 12-Year Prospective Study of Childhood Herpes Simplex Encephalitis: Is There a Broader Spectrum of Disease? 2007 ·PEDIATRICS ·Jorina Elbers, Ari Bitnun, Susan E. Richardson, Elizabeth Ford-Jones, Raymond Tellier, Rachel M. Wald, Martin Petric, Hanna Kolski, Helen Heurter, Daune MacGregor	95
11	Optimization of a DNA Vaccine Against SARS 2007 ·DNA and Cell Biology ·Alexander N. Zakhartchouk, (unknown), (unknown), Martin Petric, Lorne A. Babiuk	15
12	Detection of RNA in purified cytomegalovirus virions 2004 ·Virus Research ·(unknown), Martha Brown, Raymond Tellier, Martin Petric, Tony Mazzulli	11
13	Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis 2002 ·Journal of Clinical Investigation ·Mary Anne Opavsky, Tami A. Martino, Marlene Rabinovitch, Josef Penninger, Chris Richardson, Martin Petric, (unknown), Lisa Butcher, Janice Chan, Peter P. Liu	89
14	Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis 2002 ·Journal of Clinical Investigation ·Mary Anne Opavsky, Tami A. Martino, Marlene Rabinovitch, Josef Penninger, Chris G. Richardson, Martin Petric, (unknown), Lisa Butcher, (unknown), Peter P. Liu	5
15	Serum Concentrations, Efficacy, and Safety of a New, Intravenously Administered Varicella Zoster Immune Globulin in Pregnant Women 2002 ·The Journal of Clinical Pharmacology ·Gideon Koren, Deborah Money, Marc Boucher, Fred Y. Aoki, Martin Petric, (unknown), (unknown), Valencia P. Remple, (unknown), (unknown), (unknown), (unknown), Ronen Loebstein	18
16	Utility of Semiquantitative Polymerase Chain Reaction for Epstein‐Barr Virus to Measure Virus Load in Pediatric Organ Transplant Recipients with and without Posttransplant Lymphoproliferative Disease 2001 ·Clinical Infectious Diseases ·Upton Allen, Diane Hébert, Martin Petric, Raymond Tellier, Dat Tran, Riccardo Superina, Derek Stephens, Lori J. West, Samia Wasfy, Susan C. Nelson	34
17	The Coxsackie-Adenovirus Receptor (CAR) Is Used by Reference Strains and Clinical Isolates Representing All Six Serotypes of Coxsackievirus Group B and by Swine Vesicular Disease Virus 2000 ·Virology ·Tami A. Martino, Martin Petric, Hana M. Weingartl, Jeffrey M. Bergelson, Mary Anne Opavsky, Christopher D. Richardson, John F. Modlin, Robert W. Finberg, Kevin C. Kain, Norman Willis, Charles J. Gauntt, Peter P. Liu	110
18	Cardiovirulent Coxsackieviruses and the Decay-Accelerating Factor (CD55) Receptor 1998 ·Virology ·Tami A. Martino, Martin Petric, Martha Brown, Karen Aitken, Charles J. Gauntt, Christopher D. Richardson, (unknown), Peter P. Liu	73
19	Characterization of Torovirus from Human Fecal Specimens 1997 ·Virology ·(unknown), Bo Luan, John Devenish, Raymond Tellier, Martin Petric	33
20	Characterization of platelet‐reactive antibodies in children with varicella‐associated acute immune thrombocytopenic purpura (ITP) 1996 ·British Journal of Haematology ·J. Fraser Wright, Victor S. Blanchette, Hong Wang, Naveen Arya, Martin Petric, John W. Semple, (unknown), John Freedman	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact